You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cross-reacting antibodies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Occurrence of Antibodies Cross-reacting With Autoantigens in

Recruiting
  • Epstein-Barr Virus (EBV) Infection
  • Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Nov 8, 2021

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

Gonorrhea Trial in Kilifi (4CMenB (Bexsero®) vaccine)

Completed
  • Gonorrhea
  • 4CMenB (Bexsero®) vaccine
  • Kilifi, Kenya
    KEMRI-Wellcome Trust Research Programme
Apr 13, 2022

Diabetes, Type 2 Trial in Pembroke Pines (Semaglutide J, Semaglutide B)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide J
  • Semaglutide B
  • (no location specified)
Aug 10, 2022

Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19

Completed
  • Covid19
  • IgG SARS CoV 2 antibodies
  • Lahore, Punjab, Pakistan
    Lahore General Hospital
Feb 12, 2022

Yellow Fever Trial in Eldorado, Obera, Posadas (Serological study after yellow fever vaccination)

Enrolling by invitation
  • Yellow Fever
  • Serological study after yellow fever vaccination
  • Eldorado, Misiones, Argentina
  • +2 more
Dec 9, 2022

Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

Recruiting
  • Nasopharyngeal Carcinoma
  • EBV antibodies test
  • EBV DNA test
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022

COVID-2019 in Participating Organizations.

Completed
Has Results
  • Covid19
  • ELISA test for the antibodies to COVID-2019.
  • Kyiv, Ukraine
  • +6 more
Sep 28, 2021

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Placebo (semaglutide)
  • Birmingham, Alabama
  • +73 more
Jan 13, 2023

Helminth Infection Plus COVID-19 Infection on Immune Response

Recruiting
  • COVID-19
    • Chennai, Tamilnadu, India
      National Institute for Research in Tuberculosis - International
    Dec 2, 2022

    Diabetes, Type 2 Trial in Neuss (NNC0148-0287sema, Semaglutide, NNC0148-0287)

    Completed
    • Diabetes Mellitus, Type 2
    • Neuss, Germany
      Novo Nordisk Investigational Site
    Sep 28, 2021

    AntiDFS70 Lupus Nephritis

    Recruiting
    • Systemic Lupus Erythematosus
    • anti dfs70 antibodies
    • Sohag, Egypt
      Sohag university Hospital
    Nov 6, 2023

    COVID-19 Trial in New Taipei City (Covid19 Vaccination dose)

    Recruiting
    • COVID-19
    • Covid19 Vaccination dose
    • New Taipei City, Taiwan
      TuCheng Hospital
    Apr 24, 2023

    Metropolitan Area of Buenos Aires

    Not yet recruiting
    • Dengue
    • Flavivirus Infections
    • Dengue Immunoglobulin G antibodies performed with ELISA
    • (no location specified)
    Jun 21, 2023

    Intracranial Stenosis in Patients With Antiphospholipid Syndrome

    Not yet recruiting
    • Antiphospholipid Syndrome
    • +2 more
    • Imaging assessment
    • +2 more
    • Hong Kong, Hong Kong
      Chinese University of Hong Kong
    Oct 16, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

    Completed
    Has Results
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +107 more
    Jul 11, 2022

    Intestinal Anti-transglutaminase Antibodies

    Recruiting
    • Coeliac Disease
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Mar 15, 2023

      Population-based Age-stratified Seroepidemiological

      Not yet recruiting
      • Seroprevalence
      • +2 more
        • Sarajevo, Bosnia and Herzegovina
          Institute for Transfusion Medicine of the Federation of Bosnia a
        Nov 16, 2021

        Associated With Mental Fatigue in Graves' Disease

        Recruiting
        • Graves Disease
        • +4 more
          • Gothenburg, Sweden
            Department of Endocrinology, Sahlgrenska University Hospital
          Jan 4, 2023

          Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

          Completed
          Has Results
          • Diabetes
          • Diabetes Mellitus, Type 2
          • Tuscumbia, Alabama
          • +105 more
          Jul 11, 2022

          Antiphospholipid Antibodies and Microparticles in Immune

          Not yet recruiting
          • Thrombosis
          • Antiphospholipid antibodies
          • (no location specified)
          Apr 25, 2023

          Acquiring Convalescent Specimens for COVID-19 Antibodies

          Completed
          • COVID-19
          • +2 more
          • Blood draw
          • New York, New York
            Columbia University Irving Medical Center/NYP
          Jul 18, 2022

          Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

          Completed
          Has Results
          • Diabetes
          • Diabetes Mellitus, Type 2
          • Lancaster, California
          • +104 more
          Jul 11, 2022

          ERT in Pompe Disease: Elucidation of Molecular Structures

          Not yet recruiting
          • Pompe-Disease
            • Rüsselsheim, Hessen, Germany
              Centre for Analytical Biochemistry
            Jan 30, 2023

            HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

            Active, not recruiting
            • HIV-1-infection
            • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
            • Amsterdam, Noord-Holland, Netherlands
              Amsterdam University Medical Centers, location AMC
            Jan 31, 2023